News
Home News
December, 2020
NanoMedSyn has signed a 3-year Innovation Contract with the Occitanie...
Lire la suite
July, 2020
Dr. Marcel Garcia, co-founder and Scientific Director, is appointed President...
Lire la suite
March, 2018
Shire and NanomedSyn enter into research agreement for potential lysosomal...
Lire la suite
October, 2017
NanoMedSyn develops an efficient treatment for refractory Pompe disease published...
Lire la suite
October, 2016
First NanoMedSyn studies to improve Pompe disease treatment published by...
Lire la suite
September, 2016
Orphan designation was granted by European commission for the recombinant...
Lire la suite
November, 2013
NanoMedSyn s'implique dans l'organisation du congrès international RARE 2013. RARE...
Lire la suite
{"slide_show":3,"slide_scroll":1,"dots":"true","arrows":"true","autoplay":"true","autoplay_interval":2000,"speed":300,"loop":"true","design":"design-1"}